cont crypto- Top Related searches

Ningde's business in Europe has made progress. Through cooperation with local European giants, it has invested 30 billion RMB, with each party holding 50% of the shares. This is a new mode of exploring the sea! It is worth noting that this cooperation with Stellantis is mainly to supply lithium iron batteries and drive a new round of electrification in Europe through Ferrous lithium phosphate parity technology, which is a new opportunity from 0 to 1.Easy to change the world: shareholders intend to reduce their holdings by no more than 3.05% in total;Ningde's business in Europe has made progress. Through cooperation with local European giants, it has invested 30 billion RMB, with each party holding 50% of the shares. This is a new mode of exploring the sea! It is worth noting that this cooperation with Stellantis is mainly to supply lithium iron batteries and drive a new round of electrification in Europe through Ferrous lithium phosphate parity technology, which is a new opportunity from 0 to 1.

China Research Institute: Wang Xiuyun reduced its shareholding by 1%. At present, the company has not directly involved in the application field of humanoid robots.Shanghai builds a merger and reorganization head company, and Ning Wang magnifies the move. The bull market still needs to be believed.This "moderately loose" statement the day before yesterday is definitely a major positive. Yesterday, A shares opened higher and went lower, but it was still expected to be too full! The high pressure level of 3500 was superimposed, so it dropped sharply. After-hours, the national society issued a document to interpret "moderate easing", and everyone understands the signal! This is a kind of expected management, which embodies the intention of caring for the economy and the stock market.

True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.However, it is a great pity that the China stock market has never had a history of retail investors and institutions getting rich together. Don't deal with hot money and quantification! Foreign investment in A-shares has also become stale and has become fond of speculation. There are always too many routines to create A shares, which is too tiring to play, and the experience is really bad.